Welcome to PsychiatryAI.com: [PubMed] - Psychiatry AI Latest

Adult epilepsy

Evidence

Lancet. 2023 Jul 14:S0140-6736(23)01048-6. doi: 10.1016/S0140-6736(23)01048-6. Online ahead of print.

ABSTRACT

Epilepsy is a common medical condition that affects people of all ages, races, social classes, and geographical regions. Diagnosis of epilepsy remains clinical, and ancillary investigations (electroencephalography, imaging, etc) are of aid to determine the type, cause, and prognosis. Antiseizure medications represent the mainstay of epilepsy treatment: they aim to suppress seizures without adverse events, but they do not affect the underlying predisposition to generate seizures. Currently available antiseizure medications are effective in around two-thirds of patients with epilepsy. Neurosurgical resection is an effective strategy to reach seizure control in selected individuals with drug-resistant focal epilepsy. Non-pharmacological treatments such as palliative surgery (eg, corpus callosotomy), neuromodulation techniques (eg, vagus nerve stimulation), and dietary interventions represent therapeutic options for patients with drug-resistant epilepsy who are not suitable for resective brain surgery.

PMID:37459868 | DOI:10.1016/S0140-6736(23)01048-6

Document this CPD Copy URL Button

Google

Google Keep Add to Google Keep

LinkedIn Share Share on Linkedin Share on Linkedin

Estimated reading time: 3 minute(s)

Latest: Psychiatryai.com #RAISR4D

Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️

Real-Time Evidence Search [Psychiatry]

AI Research [Andisearch.com]

Adult epilepsy

Copy WordPress Title

🌐 90 Days

Evidence Blueprint

Adult epilepsy

QR Code

☊ AI-Driven Related Evidence Nodes

(recent articles with at least 5 words in title)

More Evidence

Adult epilepsy

🌐 365 Days

Floating Tab
close chatgpt icon
ChatGPT

Enter your request.